Skip to main content
Clinical Trials/NL-OMON26191
NL-OMON26191
Recruiting
Not Applicable

Partial Breast Radiotherapy in Low-risk Breast cancer group using a MR-guided adaptive approach; a phase II study

Amsterdam UMC, location VUmc0 sites50 target enrollmentTBD

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Not specified
Sponsor
Amsterdam UMC, location VUmc
Enrollment
50
Status
Recruiting
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
2 years ago
Study Type
Observational non invasive

Investigators

Sponsor
Amsterdam UMC, location VUmc

Eligibility Criteria

Inclusion Criteria

  • Good candidates for partial breast irradiation according to the GEC\-ESTRO recommendations are patients selected in the low\-risk group. In order to be eligible to participate in this study, a subject must meet all of the following criteria:
  • \-Age \> 50 years
  • \-WHO performance score 0\-2
  • \-Pathology proven breast cancer with following histology: invasive ductal carcinoma, mucinous, tubular, medullary, colloid cc, and associated LCIS
  • \-Any histologic grade
  • \-Any hormonal receptor status
  • \-T\-stage: Tumor size \= 3cm (pT1\-2\)
  • \-N\-stage: No positive lymph nodes examined by sentinel lymph node biopsy or axillary lymph node dissection (at least 6 nodes pathologically examined)
  • \-Radical resection of tumor with \= 2mm surgical margin free of tumour
  • \-All patients should be able to undergo MRI scans

Exclusion Criteria

  • According to the GEC\-ESTRO recommendations, subject who meets any of the following criteria will be excluded from participation in this study:
  • \-Breast cancer histology of invasive lobular carcinoma, ductal carcinoma in situ sec
  • \-Breast cancer with a multicentric or multifocality character
  • \-An extensive intraductal component in pathology examination
  • \-Lympho\-vascular invasion in the pathology examination
  • \-Treatment with neoadjuvant chemotherapy before lumpectomy
  • \-Breast conserving surgery with an oncoplastic breast surgery technique
  • \-Re\-excision of tumour in ipsilateral breast
  • \-Open surgical wound or wound infection
  • \-Previous irradiation in the ipsilateral breast

Outcomes

Primary Outcomes

Not specified

Similar Trials